Myeloid-PD-1 expression has been shown in ovarian cancer (115), melanoma (125), gastric cancer (121), NSCLC (98), pleural mesothelioma (112), etc, and generally increased with tumor progression. This evidence concerns the gene PDCD1 and neoplasm.